Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma

NCT00003007 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL: recombinant interferon alfa
BIOLOGICAL: sargramostim
DRUG: cyclophosphamide
DRUG: dexamethasone
DRUG: melphalan
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

University of Tennessee